Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines by Yanyan Zhang, Liang He, Dorothée.

Slides:



Advertisements
Similar presentations
Respiration 2012;83:74–80 - DOI: /
Advertisements

An aptamer-based targeted delivery of miR-26a protects mice against chemotherapy toxicity while suppressing tumor growth by Toshihiko Tanno, Peng Zhang,
Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact.
by Jad I. Belle, David Langlais, Jessica C
Gene transfer into hematopoietic stem cells reduces HLH manifestations in a murine model of Munc13-4 deficiency by Tayebeh Soheili, Amandine Durand, Fernando.
Role of Natural Killer Cells in Intravenous Immunoglobulin–Induced Graft-versus-Host Disease Inhibition in NOD/LtSz-scidIL2rg−/− (NSG) Mice  Joëlle Gregoire-Gauthier,
by Alexis S. Bailey, Shuguang Jiang, Michael Afentoulis, Christina I
Characterization and quantification of clonal heterogeneity among hematopoietic stem cells: a model-based approach by Ingo Roeder, Katrin Horn, Hans-Bernd.
Identification of Stem Cell Transcriptional Programs Normally Expressed in Embryonic and Neural Stem Cells in Alloreactive CD8+ T Cells Mediating Graft-versus-Host.
Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34+ cells transplanted into conditioned NOD/SCID recipients by Anna.
Ping Zhang, Jieying Wu, Divino Deoliveira, Nelson J. Chao, Benny J
Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells by Christian P. Kalberer, Uwe Siegler, and Aleksandra Wodnar-Filipowicz.
Volume 25, Issue 9, Pages (September 2017)
by Silke Huber, Reinhard Hoffmann, Femke Muskens, and David Voehringer
Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis by Ronan Chaligné, Chloé James, Carole Tonetti, Rodolphe Besancenot,
by Prabal Banerjee, Adam Tripp, Michael D
MLL leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing by Corina Schneidawind, Johan Jeong,
by Xiaowu Zhang, and Ruibao Ren
Francesca Ficara, Mark J. Murphy, Min Lin, Michael L. Cleary 
Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy by Mark P. Chao, Chad Tang, Russell K. Pachynski,
Ikaros is required for plasmacytoid dendritic cell differentiation
Jacob Andrade, Shundi Ge, Goar Symbatyan, Michael S. Rosol, Arthur J
AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia by Donya Moradi Manesh, Jad El-Hoss, Kathryn.
Distinct but phenotypically heterogeneous human cell populations produce rapid recovery of platelets and neutrophils after transplantation by Alice M.
Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonists by Christopher T.
by Signe Hässler, Chris Ramsey, Mikael C
Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction by Francesca.
Identification of cancer stem cells in a Tax-transgenic (Tax-Tg) mouse model of adult T-cell leukemia/lymphoma by Jumpei Yamazaki, Takuo Mizukami, Kazuya.
by Hyung-Gyoon Kim, Kyoko Kojima, C. Scott Swindle, Claudiu V
A knock-in mouse strain facilitates dynamic tracking and enrichment of MEIS1 by Ping Xiang, Wei Wei, Nicole Hofs, Jack Clemans-Gibbon, Tobias Maetzig,
TLR5 signaling in murine bone marrow induces hematopoietic progenitor cell proliferation and aids survival from radiation by Benyue Zhang, Damilola Oyewole-Said,
Distinct classes of c-Kit–activating mutations differ in their ability to promote RUNX1-ETO–associated acute myeloid leukemia by Heidi J. Nick, Hyung-Gyoon.
Jacob Andrade, Shundi Ge, Goar Symbatyan, Michael S. Rosol, Arthur J
Volume 3, Issue 5, Pages (November 2014)
Soluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia by Shahrzad Jalali, Tammy Price-Troska, Jonas Paludo, Jose Villasboas, Hyo-Jin.
Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes by Abdullah Mahmood Ali, Yumin Huang,
Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models by Paola Rivera-Munoz, Anouchka P. Laurent,
Replacing mouse BAFF with human BAFF does not improve B-cell maturation in hematopoietic humanized mice by Julie Lang, Bicheng Zhang, Margot Kelly, Jacob.
Volume 25, Issue 9, Pages (September 2017)
Accelerated, but not conventional, radiotherapy of murine B-cell lymphoma induces potent T cell–mediated remissions by Suparna Dutt, Michelle B. Atallah,
Robust adaptive immune response against Babesia microti infection marked by low parasitemia in a murine model of sickle cell disease by Woelsung Yi, Weili.
Volume 10, Issue 5, Pages (November 2004)
PRO 140 Monoclonal Antibody to CCR5 Prevents Acute Xenogeneic Graft-versus-Host Disease in NOD-scid IL-2Rynull Mice  Denis R. Burger, Yvonne Parker, Kathryn.
Host Basophils Are Dispensable for Induction of Donor T Helper 2 Cell Differentiation and Severity of Experimental Graft-versus-Host Disease  Isao Tawara,
CXCR5 and ICOS expression identifies a CD8 T-cell subset with TFH features in Hodgkin lymphomas by Kieu-Suong Le, Patricia Amé-Thomas, Karin Tarte, Françoise.
FGF-2 signaling mediates expansion of HSPCs
Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells by Xiaoli Wang, Cing Siang Hu, Bruce Petersen, Jiajing.
Mouse acute leukemia develops independent of self-renewal and differentiation potentials in hematopoietic stem and progenitor cells by Fang Dong, Haitao.
HSC extrinsic sex-related and intrinsic autoimmune disease–related human B-cell variation is recapitulated in humanized mice by Chiara Borsotti, Nichole.
VAY-736 combines effectively with ibrutinib in vivo.
Volume 43, Issue 2, Pages (August 2015)
Volume 16, Issue 5, Pages (May 2002)
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells by Mia Eriksson, Pablo Peña-Martínez,
Ravindra Majeti, Christopher Y. Park, Irving L. Weissman 
Volume 15, Issue 3, Pages (April 2016)
by Geling Li, Emily Waite, and Julie Wolfson
Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate hematopoietic stem and progenitor cells by Xi Jin, Tingting Qin, Meiling Zhao, Nathanael.
Volume 17, Issue 4, Pages (October 2002)
Volume 4, Issue 2, Pages (February 2015)
Human hematopoietic stem cell maintenance and myeloid cell development in next-generation humanized mouse models by Trisha R. Sippel, Stefan Radtke, Tayla.
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia by Ross Kinstrie, Dimitris Karamitros, Nicolas Goardon, Heather Morrison,
Donor and recipient BAL T cells are phenotypically and functionally memory T cells. Donor and recipient BAL T cells are phenotypically and functionally.
Differential expression of TRM markers by donor- and recipient-derived T cells with time. Differential expression of TRM markers by donor- and recipient-derived.
FVIII expression by its native promoter sustains long-term correction avoiding immune response in hemophilic mice by Simone Merlin, Rosella Famà, Ester.
Increased reconstitution of human NK cells in NSG hIL-7xhIL-15 humanized mice. Increased reconstitution of human NK cells in NSG hIL-7xhIL-15 humanized.
Comparison of conventional NSG and hIL-7 expressing NSG humanized mice
TH-302 has antileukemia activity in an in vivo primary AML xenograft murine model. TH-302 has antileukemia activity in an in vivo primary AML xenograft.
Granulocyte colony-stimulating factor mobilizes dormant hematopoietic stem cells without proliferation in mice by Jeffrey M. Bernitz, Michael G. Daniel,
CD123 CAR T cells for the treatment of myelodysplastic syndrome
Presentation transcript:

Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines by Yanyan Zhang, Liang He, Dorothée Selimoglu-Buet, Chloe Jego, Margot Morabito, Christophe Willekens, M'boyba Khadija Diop, Patrick Gonin, Valérie Lapierre, Nathalie Droin, Eric Solary, and Fawzia Louache BloodAdv Volume 1(14):972-979 June 13, 2017 © 2017 by The American Society of Hematology

Yanyan Zhang et al. Blood Adv 2017;1:972-979 © 2017 by The American Society of Hematology

Engraftment of CMML CD34+ cells in NSG and NSGS mice. Engraftment of CMML CD34+cells in NSG and NSGS mice. (A) General experimental procedure for engraftment. CD34+ cells were sorted from PB or BM samples collected from CMML patients using the MACS system (Miltenyi Biotec). One to 6 female mice, 6 to 8 weeks old, were irradiated at 2.5 Gy with a radiograph irradiator and IV injected within 24 hours with CD34+ cells suspended in 200 µL PBS. Human CD45+CD33+ cells were identified by flow cytometry in mouse blood samples collected at indicated time points postengraftment into NSG (B) or NSGS (D, left) or both (D, right) mice and in mouse BM samples taken from NSG (C) or NSGS (E) or both (F) mice when euthanized, 12 to 16 weeks after transplantation of cells from indicated samples. Each circle/square represents an individual mouse. “S” indicates the sample number. NSG mice are indicated by empty blue circles and NSGS mice by empty red squares. Yanyan Zhang et al. Blood Adv 2017;1:972-979 © 2017 by The American Society of Hematology

Characterization of cells that engrafted in NSG and NSGS mice. Characterization of cells that engrafted in NSG and NSGS mice. (A) The fraction of human CD45+ (hCD45+) cells was measured by flow cytometry in blood, BM, and spleen of NSG (empty blue circles) and NSGS (empty red squares) mice engrafted with indicated CMML samples and euthanized 12 to 16 weeks after transplantation. (B) Hematoxylin and eosin (HE) staining and immunohistochemical analysis of hCD45+ cells on the BM, spleen, and liver of NSG (left panels) or NSGS (right panels) mice engrafted with CMML CD34+ cells sorted from S994. Original magnification ×200. (C) Concentration of human GM-CSF (hGM-CSF), SCF (hSCF), and IL-3 (hIL-s) detected in the plasma, BM, spleen, and liver of NSG (empty blue circles) and NSGS (empty red squares) mice. Yanyan Zhang et al. Blood Adv 2017;1:972-979 © 2017 by The American Society of Hematology

Multiparameter flow cytometry analysis of hCD45+ cells in the BM of engrafted mice. Multiparameter flow cytometry analysis of hCD45+cells in the BM of engrafted mice. (A) Representative dot plot of flow cytometry analysis for immunophenotype of BM from NSG and NSGS mice xenografted from S944. The numbers listed represent the percent of human cells within gates P1 and P2 shown in left panel. (B) Percentage of human hCD45+ cells (left) within gates P1 and P2 calculated from NSG (11 patients) and NSGS (8 patients) primary mice 12 to 16 weeks posttransplantation. Each circle/square represents the mean percentage of human cells in different mice reconstituted with the same patient. Indicated fraction of cells among hCD45+ cells (right panel) in BM samples collected. No statistical differences were found in the percentages of cells expressing the different markers including CD34, CD15, and CD14 (Mann-Whitney U test). (C) Cytomorphology of human cells sorted from BM of NSG (left panels) and NSGS (right panels) recipient mouse xenografted from patient (S994). Black arrows indicate promonocytes and monoblasts; red arrows indicate myeloblasts. Original magnification ×500 (top panels) and ×1000 (bottom panels). (D) Genetic variants whose allele frequency (VAF) was measured in patient cells before and after engraftment in an NSGS mouse. Each dot represents 1 given mutation among screened genes. Yanyan Zhang et al. Blood Adv 2017;1:972-979 © 2017 by The American Society of Hematology

Secondary engraftment of CMML cells. Secondary engraftment of CMML cells. (A) General experimental procedure for engraftment. Human cells were sorted from BM samples collected from primary mice and injected to secondary NSG or NSGS mice. (B) Comparison of secondary transplantation of NSG (green and purple circles) and NSGS (red and blue squares) mice. Multiparametric flow cytometry was used to identify the immunophenotype of human cells (C) and representative dot plots of flow cytometry of BM cells from primary and secondary recipient NSGS mice xenografted from S788 (D). Yanyan Zhang et al. Blood Adv 2017;1:972-979 © 2017 by The American Society of Hematology